Dolby Laboratories, Inc. (NYSE: DLB) Stock Competitors & Peer Comparison

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, IBM has a market cap of 223.5B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while IBM trades at $237.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas IBM's P/E ratio is 19.96. In terms of profitability, DLB's ROE is +0.09%, compared to IBM's ROE of +0.34%. Regarding short-term risk, DLB is less volatile compared to IBM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check IBM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, ACN has a market cap of 112.2B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while ACN trades at $183.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas ACN's P/E ratio is 13.38. In terms of profitability, DLB's ROE is +0.09%, compared to ACN's ROE of +0.25%. Regarding short-term risk, DLB is less volatile compared to ACN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ACN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, INFY has a market cap of 48.8B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while INFY trades at $12.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas INFY's P/E ratio is 14.49. In terms of profitability, DLB's ROE is +0.09%, compared to INFY's ROE of +0.33%. Regarding short-term risk, DLB is less volatile compared to INFY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check INFY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, FI has a market cap of 34.3B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while FI trades at $63.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas FI's P/E ratio is 9.86. In terms of profitability, DLB's ROE is +0.09%, compared to FI's ROE of +0.11%. Regarding short-term risk, DLB is less volatile compared to FI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check FI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, FISV has a market cap of 27.8B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while FISV trades at $52.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas FISV's P/E ratio is 8.05. In terms of profitability, DLB's ROE is +0.09%, compared to FISV's ROE of +0.11%. Regarding short-term risk, DLB is less volatile compared to FISV. This indicates lower risk in terms of short-term price fluctuations for DLB.Check FISV's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CTSH has a market cap of 27.4B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CTSH trades at $60.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CTSH's P/E ratio is 11.06. In terms of profitability, DLB's ROE is +0.09%, compared to CTSH's ROE of +0.15%. Regarding short-term risk, DLB is less volatile compared to CTSH. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CTSH's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, FIS has a market cap of 21B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while FIS trades at $40.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas FIS's P/E ratio is 6.75. In terms of profitability, DLB's ROE is +0.09%, compared to FIS's ROE of +0.23%. Regarding short-term risk, DLB is less volatile compared to FIS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check FIS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, BR has a market cap of 20.4B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while BR trades at $176.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas BR's P/E ratio is 18.26. In terms of profitability, DLB's ROE is +0.09%, compared to BR's ROE of +0.40%. Regarding short-term risk, DLB is less volatile compared to BR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, WIT has a market cap of 19.3B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while WIT trades at $1.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas WIT's P/E ratio is 14.47. In terms of profitability, DLB's ROE is +0.09%, compared to WIT's ROE of +0.15%. Regarding short-term risk, DLB is less volatile compared to WIT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check WIT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, LDOS has a market cap of 18.4B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while LDOS trades at $146.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas LDOS's P/E ratio is 11.99. In terms of profitability, DLB's ROE is +0.09%, compared to LDOS's ROE of +0.28%. Regarding short-term risk, DLB is less volatile compared to LDOS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check LDOS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CDW has a market cap of 17.5B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CDW trades at $137.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CDW's P/E ratio is 13.10. In terms of profitability, DLB's ROE is +0.09%, compared to CDW's ROE of +0.43%. Regarding short-term risk, DLB is less volatile compared to CDW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CDW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, GIB has a market cap of 16B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while GIB trades at $74.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas GIB's P/E ratio is 12.03. In terms of profitability, DLB's ROE is +0.09%, compared to GIB's ROE of +0.17%. Regarding short-term risk, DLB is less volatile compared to GIB. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GIB's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, IREN has a market cap of 15.3B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while IREN trades at $42.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas IREN's P/E ratio is -29.75. In terms of profitability, DLB's ROE is +0.09%, compared to IREN's ROE of +0.03%. Regarding short-term risk, DLB is less volatile compared to IREN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check IREN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CACI has a market cap of 14.6B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CACI trades at $662.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CACI's P/E ratio is 22.21. In terms of profitability, DLB's ROE is +0.09%, compared to CACI's ROE of +0.13%. Regarding short-term risk, DLB is more volatile compared to CACI. This indicates higher risk in terms of short-term price fluctuations for DLB.Check CACI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, WSE has a market cap of 12.5B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while WSE trades at $12.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas WSE's P/E ratio is 12.76. In terms of profitability, DLB's ROE is +0.09%, compared to WSE's ROE of +0.26%. Regarding short-term risk, DLB is less volatile compared to WSE. This indicates lower risk in terms of short-term price fluctuations for DLB.Check WSE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, AUR has a market cap of 12.1B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while AUR trades at $6.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas AUR's P/E ratio is -12.91. In terms of profitability, DLB's ROE is +0.09%, compared to AUR's ROE of -0.43%. Regarding short-term risk, DLB is less volatile compared to AUR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check AUR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, JKHY has a market cap of 11.6B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while JKHY trades at $163.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas JKHY's P/E ratio is 22.81. In terms of profitability, DLB's ROE is +0.09%, compared to JKHY's ROE of +0.23%. Regarding short-term risk, DLB is less volatile compared to JKHY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check JKHY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, APLD has a market cap of 8.1B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while APLD trades at $28.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas APLD's P/E ratio is -40.33. In terms of profitability, DLB's ROE is +0.09%, compared to APLD's ROE of -0.17%. Regarding short-term risk, DLB is less volatile compared to APLD. This indicates lower risk in terms of short-term price fluctuations for DLB.Check APLD's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, GDS has a market cap of 6.5B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while GDS trades at $33.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas GDS's P/E ratio is 13.44. In terms of profitability, DLB's ROE is +0.09%, compared to GDS's ROE of +0.13%. Regarding short-term risk, DLB is less volatile compared to GDS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GDS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, INGM has a market cap of 6.2B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while INGM trades at $27.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas INGM's P/E ratio is 8.90. In terms of profitability, DLB's ROE is +0.09%, compared to INGM's ROE of +0.10%. Regarding short-term risk, DLB is less volatile compared to INGM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check INGM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, G has a market cap of 6.2B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while G trades at $36.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas G's P/E ratio is 9.58. In terms of profitability, DLB's ROE is +0.09%, compared to G's ROE of +0.23%. Regarding short-term risk, DLB is less volatile compared to G. This indicates lower risk in terms of short-term price fluctuations for DLB.Check G's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, EPAM has a market cap of 5.6B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while EPAM trades at $107.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas EPAM's P/E ratio is 8.54. In terms of profitability, DLB's ROE is +0.09%, compared to EPAM's ROE of +0.11%. Regarding short-term risk, DLB is less volatile compared to EPAM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check EPAM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, EXLS has a market cap of 5.6B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while EXLS trades at $37.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas EXLS's P/E ratio is 18.06. In terms of profitability, DLB's ROE is +0.09%, compared to EXLS's ROE of +0.28%. Regarding short-term risk, DLB is less volatile compared to EXLS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check EXLS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, SAIC has a market cap of 5.4B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while SAIC trades at $128.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas SAIC's P/E ratio is 11.55. In terms of profitability, DLB's ROE is +0.09%, compared to SAIC's ROE of +0.27%. Regarding short-term risk, DLB is less volatile compared to SAIC. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SAIC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, NIQ has a market cap of 5.1B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while NIQ trades at $18.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas NIQ's P/E ratio is 48.14. In terms of profitability, DLB's ROE is +0.09%, compared to NIQ's ROE of -0.47%. Regarding short-term risk, DLB is less volatile compared to NIQ. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NIQ's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, PSN has a market cap of 5B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while PSN trades at $47.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas PSN's P/E ratio is 20.09. In terms of profitability, DLB's ROE is +0.09%, compared to PSN's ROE of +0.06%. Regarding short-term risk, DLB is less volatile compared to PSN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check PSN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, PAY has a market cap of 4.8B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while PAY trades at $39.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas PAY's P/E ratio is 46.22. In terms of profitability, DLB's ROE is +0.09%, compared to PAY's ROE of +0.15%. Regarding short-term risk, DLB is less volatile compared to PAY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check PAY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, NSIT has a market cap of 4.5B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while NSIT trades at $147.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas NSIT's P/E ratio is 12.30. In terms of profitability, DLB's ROE is +0.09%, compared to NSIT's ROE of +0.13%. Regarding short-term risk, DLB is less volatile compared to NSIT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NSIT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, NCR has a market cap of 3.8B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while NCR trades at $27.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas NCR's P/E ratio is 49.24. In terms of profitability, DLB's ROE is +0.09%, compared to NCR's ROE of +0.17%. Regarding short-term risk, DLB is less volatile compared to NCR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NCR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, WNS has a market cap of 3.3B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while WNS trades at $76.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas WNS's P/E ratio is 21.36. In terms of profitability, DLB's ROE is +0.09%, compared to WNS's ROE of +0.09%. Regarding short-term risk, DLB is more volatile compared to WNS. This indicates higher risk in terms of short-term price fluctuations for DLB.Check WNS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CSQR has a market cap of 3.2B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CSQR trades at $20.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CSQR's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to CSQR's ROE of N/A. Regarding short-term risk, DLB is less volatile compared to CSQR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CSQR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, KD has a market cap of 2.7B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while KD trades at $12.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas KD's P/E ratio is 12.89. In terms of profitability, DLB's ROE is +0.09%, compared to KD's ROE of +0.29%. Regarding short-term risk, DLB is less volatile compared to KD. This indicates lower risk in terms of short-term price fluctuations for DLB.Check KD's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, PRFT has a market cap of 2.7B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while PRFT trades at $75.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas PRFT's P/E ratio is 36.34. In terms of profitability, DLB's ROE is +0.09%, compared to PRFT's ROE of +0.21%. Regarding short-term risk, DLB is more volatile compared to PRFT. This indicates higher risk in terms of short-term price fluctuations for DLB.Check PRFT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, SHAZ has a market cap of 2.3B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while SHAZ trades at $65.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas SHAZ's P/E ratio is -2.15. In terms of profitability, DLB's ROE is +0.09%, compared to SHAZ's ROE of -1.57%. Regarding short-term risk, DLB is less volatile compared to SHAZ. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SHAZ's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, INOD has a market cap of 2.1B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while INOD trades at $62.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas INOD's P/E ratio is 56.56. In terms of profitability, DLB's ROE is +0.09%, compared to INOD's ROE of +0.38%. Regarding short-term risk, DLB is less volatile compared to INOD. This indicates lower risk in terms of short-term price fluctuations for DLB.Check INOD's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, KEEL has a market cap of 2B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while KEEL trades at $3.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas KEEL's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to KEEL's ROE of -0.90%. Regarding short-term risk, DLB is less volatile compared to KEEL. This indicates lower risk in terms of short-term price fluctuations for DLB.Check KEEL's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, VNET has a market cap of 1.9B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while VNET trades at $6.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas VNET's P/E ratio is -5.71. In terms of profitability, DLB's ROE is +0.09%, compared to VNET's ROE of -0.40%. Regarding short-term risk, DLB is less volatile compared to VNET. This indicates lower risk in terms of short-term price fluctuations for DLB.Check VNET's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, FORTY has a market cap of 1.8B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while FORTY trades at $118.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas FORTY's P/E ratio is 28.10. In terms of profitability, DLB's ROE is +0.09%, compared to FORTY's ROE of +0.59%. Regarding short-term risk, DLB is less volatile compared to FORTY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check FORTY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, DXC has a market cap of 1.8B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while DXC trades at $10.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas DXC's P/E ratio is 3.34. In terms of profitability, DLB's ROE is +0.09%, compared to DXC's ROE of +0.04%. Regarding short-term risk, DLB is less volatile compared to DXC. This indicates lower risk in terms of short-term price fluctuations for DLB.Check DXC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, GLOB has a market cap of 1.7B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while GLOB trades at $39.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas GLOB's P/E ratio is 6.48. In terms of profitability, DLB's ROE is +0.09%, compared to GLOB's ROE of +0.05%. Regarding short-term risk, DLB is less volatile compared to GLOB. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GLOB's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, NYAX has a market cap of 1.7B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while NYAX trades at $48.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas NYAX's P/E ratio is 72.83. In terms of profitability, DLB's ROE is +0.09%, compared to NYAX's ROE of +0.04%. Regarding short-term risk, DLB is less volatile compared to NYAX. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NYAX's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, AI has a market cap of 1.6B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while AI trades at $10.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas AI's P/E ratio is -7.69. In terms of profitability, DLB's ROE is +0.09%, compared to AI's ROE of -0.64%. Regarding short-term risk, DLB is less volatile compared to AI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check AI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CNXC has a market cap of 1.6B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CNXC trades at $25.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CNXC's P/E ratio is 2.34. In terms of profitability, DLB's ROE is +0.09%, compared to CNXC's ROE of -0.42%. Regarding short-term risk, DLB is less volatile compared to CNXC. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CNXC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, BBAI has a market cap of 1.5B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while BBAI trades at $3.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas BBAI's P/E ratio is -4.59. In terms of profitability, DLB's ROE is +0.09%, compared to BBAI's ROE of -0.12%. Regarding short-term risk, DLB is less volatile compared to BBAI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BBAI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, TWKS has a market cap of 1.4B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while TWKS trades at $4.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas TWKS's P/E ratio is -12.08. In terms of profitability, DLB's ROE is +0.09%, compared to TWKS's ROE of -0.09%. Regarding short-term risk, DLB is more volatile compared to TWKS. This indicates higher risk in terms of short-term price fluctuations for DLB.Check TWKS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, MGRT has a market cap of 1.4B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while MGRT trades at $98.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas MGRT's P/E ratio is 581.18. In terms of profitability, DLB's ROE is +0.09%, compared to MGRT's ROE of +0.21%. Regarding short-term risk, DLB is less volatile compared to MGRT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check MGRT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, BBAI-WT has a market cap of 1.4B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while BBAI-WT trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas BBAI-WT's P/E ratio is -0.16. In terms of profitability, DLB's ROE is +0.09%, compared to BBAI-WT's ROE of -0.12%. Regarding short-term risk, DLB is less volatile compared to BBAI-WT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BBAI-WT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, EFOR has a market cap of 1.3B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while EFOR trades at $31.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas EFOR's P/E ratio is 7.40. In terms of profitability, DLB's ROE is +0.09%, compared to EFOR's ROE of +0.05%. Regarding short-term risk, DLB is less volatile compared to EFOR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check EFOR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CLVT has a market cap of 1.3B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CLVT trades at $2.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CLVT's P/E ratio is 2.74. In terms of profitability, DLB's ROE is +0.09%, compared to CLVT's ROE of -0.07%. Regarding short-term risk, DLB is less volatile compared to CLVT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CLVT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, BTCM has a market cap of 1.3B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while BTCM trades at $1.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas BTCM's P/E ratio is -0.53. In terms of profitability, DLB's ROE is +0.09%, compared to BTCM's ROE of -0.32%. Regarding short-term risk, DLB is less volatile compared to BTCM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BTCM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, VYX has a market cap of 1.1B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while VYX trades at $7.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas VYX's P/E ratio is 8.58. In terms of profitability, DLB's ROE is +0.09%, compared to VYX's ROE of +0.07%. Regarding short-term risk, DLB is less volatile compared to VYX. This indicates lower risk in terms of short-term price fluctuations for DLB.Check VYX's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, SIFY has a market cap of 1B. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while SIFY trades at $14.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas SIFY's P/E ratio is 0.01. In terms of profitability, DLB's ROE is +0.09%, compared to SIFY's ROE of -0.05%. Regarding short-term risk, DLB is less volatile compared to SIFY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SIFY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, ASGN has a market cap of 895M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while ASGN trades at $20.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas ASGN's P/E ratio is 9.32. In terms of profitability, DLB's ROE is +0.09%, compared to ASGN's ROE of +0.05%. Regarding short-term risk, DLB is less volatile compared to ASGN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ASGN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, SLAI has a market cap of 880.1M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while SLAI trades at $3.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas SLAI's P/E ratio is -1.40. In terms of profitability, DLB's ROE is +0.09%, compared to SLAI's ROE of -0.83%. Regarding short-term risk, DLB is less volatile compared to SLAI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SLAI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, MGIC has a market cap of 853.3M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while MGIC trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas MGIC's P/E ratio is 21.20. In terms of profitability, DLB's ROE is +0.09%, compared to MGIC's ROE of +0.11%. Regarding short-term risk, DLB is more volatile compared to MGIC. This indicates higher risk in terms of short-term price fluctuations for DLB.Check MGIC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CTLP has a market cap of 825.8M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CTLP trades at $11.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CTLP's P/E ratio is 280.00. In terms of profitability, DLB's ROE is +0.09%, compared to CTLP's ROE of +0.01%. Regarding short-term risk, DLB is more volatile compared to CTLP. This indicates higher risk in terms of short-term price fluctuations for DLB.Check CTLP's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, WYFI has a market cap of 825.6M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while WYFI trades at $21.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas WYFI's P/E ratio is -12.70. In terms of profitability, DLB's ROE is +0.09%, compared to WYFI's ROE of -0.09%. Regarding short-term risk, DLB is less volatile compared to WYFI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check WYFI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, HIVE has a market cap of 771.7M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while HIVE trades at $2.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas HIVE's P/E ratio is -3.81. In terms of profitability, DLB's ROE is +0.09%, compared to HIVE's ROE of -0.61%. Regarding short-term risk, DLB is less volatile compared to HIVE. This indicates lower risk in terms of short-term price fluctuations for DLB.Check HIVE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CLVT-PA has a market cap of 755.5M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CLVT-PA trades at $4.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CLVT-PA's P/E ratio is -7.93. In terms of profitability, DLB's ROE is +0.09%, compared to CLVT-PA's ROE of -0.07%. Regarding short-term risk, DLB is less volatile compared to CLVT-PA. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CLVT-PA's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, TASK has a market cap of 728.9M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while TASK trades at $8.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas TASK's P/E ratio is 5.39. In terms of profitability, DLB's ROE is +0.09%, compared to TASK's ROE of +0.25%. Regarding short-term risk, DLB is less volatile compared to TASK. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TASK's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, VRRM has a market cap of 706.4M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while VRRM trades at $4.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas VRRM's P/E ratio is 3.58. In terms of profitability, DLB's ROE is +0.09%, compared to VRRM's ROE of +0.15%. Regarding short-term risk, DLB is less volatile compared to VRRM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check VRRM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, NABL has a market cap of 650.8M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while NABL trades at $3.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas NABL's P/E ratio is 8.86. In terms of profitability, DLB's ROE is +0.09%, compared to NABL's ROE of -0.01%. Regarding short-term risk, DLB is less volatile compared to NABL. This indicates lower risk in terms of short-term price fluctuations for DLB.Check NABL's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, GDYN has a market cap of 647.4M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while GDYN trades at $7.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas GDYN's P/E ratio is 21.00. In terms of profitability, DLB's ROE is +0.09%, compared to GDYN's ROE of +0.01%. Regarding short-term risk, DLB is less volatile compared to GDYN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GDYN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, PHLT has a market cap of 611.6M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while PHLT trades at $7.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas PHLT's P/E ratio is -775.00. In terms of profitability, DLB's ROE is +0.09%, compared to PHLT's ROE of +0.02%. Regarding short-term risk, DLB is more volatile compared to PHLT. This indicates higher risk in terms of short-term price fluctuations for DLB.Check PHLT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, IBEX has a market cap of 478.9M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while IBEX trades at $35.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas IBEX's P/E ratio is 10.08. In terms of profitability, DLB's ROE is +0.09%, compared to IBEX's ROE of +0.32%. Regarding short-term risk, DLB is less volatile compared to IBEX. This indicates lower risk in terms of short-term price fluctuations for DLB.Check IBEX's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, XRX has a market cap of 372.7M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while XRX trades at $2.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas XRX's P/E ratio is -2.94. In terms of profitability, DLB's ROE is +0.09%, compared to XRX's ROE of -1.61%. Regarding short-term risk, DLB is less volatile compared to XRX. This indicates lower risk in terms of short-term price fluctuations for DLB.Check XRX's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, ALIT has a market cap of 363.3M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while ALIT trades at $13.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas ALIT's P/E ratio is 5.72. In terms of profitability, DLB's ROE is +0.09%, compared to ALIT's ROE of -1.59%. Regarding short-term risk, DLB is less volatile compared to ALIT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ALIT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, PSFE has a market cap of 347.8M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while PSFE trades at $6.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas PSFE's P/E ratio is 3.32. In terms of profitability, DLB's ROE is +0.09%, compared to PSFE's ROE of -0.33%. Regarding short-term risk, DLB is less volatile compared to PSFE. This indicates lower risk in terms of short-term price fluctuations for DLB.Check PSFE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, TLS has a market cap of 331.4M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while TLS trades at $4.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas TLS's P/E ratio is 24.61. In terms of profitability, DLB's ROE is +0.09%, compared to TLS's ROE of -0.16%. Regarding short-term risk, DLB is less volatile compared to TLS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TLS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, HCKT has a market cap of 273.8M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while HCKT trades at $10.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas HCKT's P/E ratio is 7.50. In terms of profitability, DLB's ROE is +0.09%, compared to HCKT's ROE of +0.22%. Regarding short-term risk, DLB is less volatile compared to HCKT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check HCKT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, BULLZ has a market cap of 260.4M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while BULLZ trades at $1.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas BULLZ's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to BULLZ's ROE of -0.01%. Regarding short-term risk, DLB is less volatile compared to BULLZ. This indicates lower risk in terms of short-term price fluctuations for DLB.Check BULLZ's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, TSSI has a market cap of 256.6M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while TSSI trades at $9.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas TSSI's P/E ratio is 18.65. In terms of profitability, DLB's ROE is +0.09%, compared to TSSI's ROE of +0.19%. Regarding short-term risk, DLB is less volatile compared to TSSI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TSSI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CNDT has a market cap of 226.4M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CNDT trades at $1.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CNDT's P/E ratio is -3.84. In terms of profitability, DLB's ROE is +0.09%, compared to CNDT's ROE of -0.30%. Regarding short-term risk, DLB is less volatile compared to CNDT. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CNDT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, XRXDW has a market cap of 218.9M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while XRXDW trades at $0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas XRXDW's P/E ratio is -0.53. In terms of profitability, DLB's ROE is +0.09%, compared to XRXDW's ROE of -1.62%. Regarding short-term risk, DLB is less volatile compared to XRXDW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check XRXDW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, UIS has a market cap of 200.1M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while UIS trades at $2.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas UIS's P/E ratio is 3.31. In terms of profitability, DLB's ROE is +0.09%, compared to UIS's ROE of +1.35%. Regarding short-term risk, DLB is less volatile compared to UIS. This indicates lower risk in terms of short-term price fluctuations for DLB.Check UIS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, SRT has a market cap of 178.3M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while SRT trades at $4.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas SRT's P/E ratio is -6.60. In terms of profitability, DLB's ROE is +0.09%, compared to SRT's ROE of -0.00%. Regarding short-term risk, DLB is more volatile compared to SRT. This indicates higher risk in terms of short-term price fluctuations for DLB.Check SRT's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CTG has a market cap of 169M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CTG trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CTG's P/E ratio is 350.00. In terms of profitability, DLB's ROE is +0.09%, compared to CTG's ROE of +0.07%. Regarding short-term risk, DLB is more volatile compared to CTG. This indicates higher risk in terms of short-term price fluctuations for DLB.Check CTG's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, DAVA has a market cap of 167.2M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while DAVA trades at $3.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas DAVA's P/E ratio is 3.90. In terms of profitability, DLB's ROE is +0.09%, compared to DAVA's ROE of -0.88%. Regarding short-term risk, DLB is less volatile compared to DAVA. This indicates lower risk in terms of short-term price fluctuations for DLB.Check DAVA's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, KORE has a market cap of 163M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while KORE trades at $9.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas KORE's P/E ratio is -4.97. In terms of profitability, DLB's ROE is +0.09%, compared to KORE's ROE of +0.48%. Regarding short-term risk, DLB is more volatile compared to KORE. This indicates higher risk in terms of short-term price fluctuations for DLB.Check KORE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, ALYA has a market cap of 110.3M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while ALYA trades at $1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas ALYA's P/E ratio is -3.42. In terms of profitability, DLB's ROE is +0.09%, compared to ALYA's ROE of -0.09%. Regarding short-term risk, DLB is less volatile compared to ALYA. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ALYA's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, WYY has a market cap of 93.3M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while WYY trades at $9.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas WYY's P/E ratio is -47.20. In terms of profitability, DLB's ROE is +0.09%, compared to WYY's ROE of -0.11%. Regarding short-term risk, DLB is less volatile compared to WYY. This indicates lower risk in terms of short-term price fluctuations for DLB.Check WYY's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CHRN has a market cap of 84.5M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CHRN trades at $23.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CHRN's P/E ratio is -4.17. In terms of profitability, DLB's ROE is +0.09%, compared to CHRN's ROE of N/A. Regarding short-term risk, DLB is less volatile compared to CHRN. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CHRN's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CSPI has a market cap of 76M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CSPI trades at $7.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CSPI's P/E ratio is -107.86. In terms of profitability, DLB's ROE is +0.09%, compared to CSPI's ROE of -0.02%. Regarding short-term risk, DLB is less volatile compared to CSPI. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CSPI's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, TTEC has a market cap of 73M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while TTEC trades at $1.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas TTEC's P/E ratio is 1.56. In terms of profitability, DLB's ROE is +0.09%, compared to TTEC's ROE of -1.62%. Regarding short-term risk, DLB is less volatile compared to TTEC. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TTEC's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, QXL has a market cap of 60.5M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while QXL trades at $4.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas QXL's P/E ratio is -90.70. In terms of profitability, DLB's ROE is +0.09%, compared to QXL's ROE of -0.14%. Regarding short-term risk, DLB is less volatile compared to QXL. This indicates lower risk in terms of short-term price fluctuations for DLB.Check QXL's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CTM has a market cap of 59M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CTM trades at $0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CTM's P/E ratio is -47.64. In terms of profitability, DLB's ROE is +0.09%, compared to CTM's ROE of -0.06%. Regarding short-term risk, DLB is less volatile compared to CTM. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CTM's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, SIFYR has a market cap of 44.3M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while SIFYR trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas SIFYR's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to SIFYR's ROE of N/A. Regarding short-term risk, DLB is less volatile compared to SIFYR. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SIFYR's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, SAIH has a market cap of 40.2M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while SAIH trades at $22.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas SAIH's P/E ratio is -3.99. In terms of profitability, DLB's ROE is +0.09%, compared to SAIH's ROE of -0.68%. Regarding short-term risk, DLB is less volatile compared to SAIH. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SAIH's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, JFU has a market cap of 31.1M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while JFU trades at $2.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas JFU's P/E ratio is 566.52. In terms of profitability, DLB's ROE is +0.09%, compared to JFU's ROE of +0.04%. Regarding short-term risk, DLB is less volatile compared to JFU. This indicates lower risk in terms of short-term price fluctuations for DLB.Check JFU's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CLPS has a market cap of 25.7M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CLPS trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CLPS's P/E ratio is -3.63. In terms of profitability, DLB's ROE is +0.09%, compared to CLPS's ROE of -0.12%. Regarding short-term risk, DLB is more volatile compared to CLPS. This indicates higher risk in terms of short-term price fluctuations for DLB.Check CLPS's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, AERTW has a market cap of 22.5M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while AERTW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas AERTW's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to AERTW's ROE of -1.14%. Regarding short-term risk, DLB is more volatile compared to AERTW. This indicates higher risk in terms of short-term price fluctuations for DLB.Check AERTW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, CHOW has a market cap of 13.8M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while CHOW trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas CHOW's P/E ratio is -4.33. In terms of profitability, DLB's ROE is +0.09%, compared to CHOW's ROE of -0.58%. Regarding short-term risk, DLB is less volatile compared to CHOW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check CHOW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, ENRDW has a market cap of 12.9M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while ENRDW trades at $0.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas ENRDW's P/E ratio is N/A. In terms of profitability, DLB's ROE is +0.09%, compared to ENRDW's ROE of N/A. Regarding short-term risk, DLB is less volatile compared to ENRDW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ENRDW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, SGLB has a market cap of 11.3M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while SGLB trades at $1.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas SGLB's P/E ratio is -1.37. In terms of profitability, DLB's ROE is +0.09%, compared to SGLB's ROE of -2.65%. Regarding short-term risk, DLB is less volatile compared to SGLB. This indicates lower risk in terms of short-term price fluctuations for DLB.Check SGLB's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, LHSW has a market cap of 9.7M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while LHSW trades at $2.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas LHSW's P/E ratio is -24.83. In terms of profitability, DLB's ROE is +0.09%, compared to LHSW's ROE of +0.32%. Regarding short-term risk, DLB is less volatile compared to LHSW. This indicates lower risk in terms of short-term price fluctuations for DLB.Check LHSW's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, LZMH has a market cap of 8.8M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while LZMH trades at $1.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas LZMH's P/E ratio is -0.34. In terms of profitability, DLB's ROE is +0.09%, compared to LZMH's ROE of -3.05%. Regarding short-term risk, DLB is less volatile compared to LZMH. This indicates lower risk in terms of short-term price fluctuations for DLB.Check LZMH's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, GLE has a market cap of 8.5M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while GLE trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas GLE's P/E ratio is -5.32. In terms of profitability, DLB's ROE is +0.09%, compared to GLE's ROE of +0.20%. Regarding short-term risk, DLB is less volatile compared to GLE. This indicates lower risk in terms of short-term price fluctuations for DLB.Check GLE's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, ARBB has a market cap of 7.6M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while ARBB trades at $4.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas ARBB's P/E ratio is -0.56. In terms of profitability, DLB's ROE is +0.09%, compared to ARBB's ROE of -0.07%. Regarding short-term risk, DLB is less volatile compared to ARBB. This indicates lower risk in terms of short-term price fluctuations for DLB.Check ARBB's competition here

Dolby Laboratories, Inc. (NYSE: DLB) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DLB stands at 6B. In comparison, TDTH has a market cap of 7.5M. Regarding current trading prices, DLB is priced at $62.70 on the NYSE, while TDTH trades at $1.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DLB currently has a P/E ratio of 14.93, whereas TDTH's P/E ratio is -0.27. In terms of profitability, DLB's ROE is +0.09%, compared to TDTH's ROE of +3.18%. Regarding short-term risk, DLB is less volatile compared to TDTH. This indicates lower risk in terms of short-term price fluctuations for DLB.Check TDTH's competition here